-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
Yubo International Biotech Ltd quarterly/annual Current Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
- Yubo International Biotech Ltd Current Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$102K, a 29.3% decline year-over-year.
- Yubo International Biotech Ltd annual Current Income Tax Expense (Benefit) for 2023 was -$299K, a 0.82% increase from 2022.
- Yubo International Biotech Ltd annual Current Income Tax Expense (Benefit) for 2022 was -$301K, a 21.9% increase from 2021.
- Yubo International Biotech Ltd annual Current Income Tax Expense (Benefit) for 2021 was -$386K, a 317% decline from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)